High Net Worth Advisory Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

High Net Worth Advisory Group’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-300	Closed	-$10K	–	741
2022 Q1	$10K	Buy	+300	New	+$8.61K	﹤0.01%	536

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

High Net Worth Advisory Group's SRRA Position: Q2 2022 in Review

High Net Worth Advisory Group sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 300 shares — an estimated $10K sold.

High Net Worth Advisory Group first reported a position in SRRA in Q1 2022 and held it in 1 quarter. The position peaked at $10K in Q1 2022. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

High Net Worth Advisory Group reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
High Net Worth Advisory Group sold 300 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $10K.
High Net Worth Advisory Group first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
High Net Worth Advisory Group's Sierra Oncology, Inc. Common Stock position peaked at $10K in Q1 2022.
109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on High Net Worth Advisory Group's 13F filing for Q2 2022, filed 10 Aug 2022.